GlassScriptPhysician profile
Mark T Brandt
NPI 1942248794
$1,334,607.32
in general payments reported to CMS, 2019-2025
68 companies · $1,217 in 2025
The $1,217 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $41K · 2021: $41K · 2022: $43K · 2023: $1.2M · 2024: $1,359 · 2025: $1,217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $1.1M · Consulting Fee: $10K · Food and Beverage: $3,800 · Travel and Lodging: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $1,145,168.00 |
| Consulting Fee | $10,000.00 |
| Food and Beverage | $3,800.07 |
| Travel and Lodging | $739.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $1,327,392.78 | 2019-2023 | |
| Pfizer INC. | $623.21 | 2019-2025 | |
| Astellas Pharma US INC | $464.83 | 2019-2024 | Xtandi, Myrbetriq |
| Blue Earth Diagnostics | $366.31 | 2019-2025 | Posluma |
| Janssen Biotech, INC. | $349.09 | 2019-2025 | Erleada |
| Dendreon Pharmaceuticals LLC | $339.12 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $319.53 | 2019-2025 | |
| Accord Healthcare, INC. | $316.64 | 2022-2025 | |
| Abbvie INC. | $301.61 | 2019-2025 | Botox |
| Urovant Sciences INC | $248.99 | 2021-2022 | |
| Coloplast Corp | $220.32 | 2019-2024 | Porges Coloplast, Speedicath, Coloplast Tfl Drive |
| Urogen Pharma, INC. | $207.32 | 2021-2025 | Jelmyto |
| Sumitomo Pharma America, INC. | $202.45 | 2023-2025 | Orgovyx, Gemtesa |
| Verity Pharmaceuticals INC. | $201.29 | 2022-2025 | Trelstar |
| Myovant Sciences INC. | $173.70 | 2021-2022 |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $162.94 | 2022-2025 | Itind System, Soltive, Olympus |
| Dentsply Ih INC. | $155.94 | 2023 | Lofric |
| Immunitybio, INC. | $154.18 | 2024-2025 | |
| Teleflex LLC | $153.45 | 2021-2025 | Urolift |
| Procept Biorobotics Corporation | $145.95 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Sun Pharmaceutical Industries INC. | $143.29 | 2022-2024 | Yonsa |
| Astrazeneca Pharmaceuticals LP | $133.05 | 2020-2023 | Lynparza |
| Tolmar Pharmaceuticals, INC. | $130.82 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $122.13 | 2019-2024 | Xiaflex, Aveed |
| Endo USA, INC. | $104.22 | 2024-2025 | Xiaflex |
| Allergan, INC. | $99.51 | 2019-2021 | |
| Travere Therapeutics, INC. | $92.12 | 2019-2020 | |
| Neotract INC. | $77.59 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $77.49 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $76.27 | 2019-2025 | Adstiladrin |
| Antares Pharma, INC. | $75.74 | 2020-2022 | |
| Laborie Medical Technologies Corp. | $73.18 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Vertex Pharmaceuticals Incorporated | $70.57 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $64.21 | 2021-2024 | Lynparza |
| Boston Scientific Corporation | $55.03 | 2021-2024 | Rezum Generator |
| Abc Home Medical Supply, INC. | $49.24 | 2022-2024 | |
| Smith+Nephew, INC. | $47.24 | 2025 | Stravix Pl |
| Abbott Laboratories | $46.39 | 2024 | Proclaim |
| Progenics Pharmaceuticals, INC. | $44.47 | 2023-2025 | Pylarify |
| Acerus Pharmaceuticals Corporation | $34.42 | 2020 | |
| Bluewind Medical | $30.77 | 2025 | Revi |
| Calyxo, INC. | $29.48 | 2024-2025 | Cvac Aspiration System |
| 180 Medical, INC. | $29.32 | 2022 | |
| Alnylam Pharmaceuticals INC. | $25.99 | 2023 | Onpattro |
| Convatec INC. | $24.64 | 2024 | |
| Genzyme Corporation | $22.22 | 2019 | |
| Rochester Medical Corporation | $21.12 | 2020 | |
| Tolmar, INC. | $20.97 | 2023 | |
| Agiliti Surgical, INC. | $20.67 | 2024 | Koelis Trinity Fusion Biopsy System, Sonablate Hifu |
| Axonics, INC. | $20.12 | 2021 | |
| Novo Nordisk INC | $19.91 | 2024 | Rivfloza |
| Tempus Ai, INC | $19.72 | 2024 | |
| Telix Pharmaceuticals | $19.67 | 2024 | Illuccix |
| Clarus Therapeutics INC. | $19.22 | 2021 | |
| Sunovion Pharmaceuticals INC. | $18.81 | 2021 | |
| Cook Medical LLC | $15.95 | 2022 | |
| Ethicon US, LLC | $15.77 | 2019 | |
| Becton, Dickinson and Company | $14.54 | 2019 | |
| Edap Technomed INC | $14.13 | 2023 | |
| Integra Lifesciences Corporation | $14.04 | 2022 | |
| Histosonics, INC. | $13.28 | 2025 | |
| Medtronic USA, INC. | $12.35 | 2020 | |
| Aesculap, INC. | $12.35 | 2019 | |
| Mission Pharmacal Company | $12.27 | 2022 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.69 | 2019 | |
| Myriad Genetic Laboratories, INC. | $11.69 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$8,184,048.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Brandt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.